Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

624
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
624
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

555
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
555
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

2.2K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.2K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

332
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
332

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lactobacillus reuteri lozenges and chemotherapy-induced oral mucositis in breast cancer outpatients: an exploratory randomized controlled trial.

Scientific reports·2026
Same author

Amplitude is not performance: interpreting motor-evoked potential findings during remimazolam-based anesthesia.

Journal of anesthesia·2026
Same author

Background for High Risk Drinking Habits Among Adult Women: A Qualitative Study of Trigger, Maintenance, and Promotion Factors.

Yonago acta medica·2026
Same author

Factors associated with smoking and risky drinking among university students in Japan.

Environmental health and preventive medicine·2026
Same author

Rare but High-consequence Cardiac Events During Thoracic Endovascular Aortic Repair: Implications for Intraoperative Vigilance.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Provu video stylet-assisted intubation under direct laryngoscopy and video laryngoscopy in high Arne score patients: a randomized clinical trial.

BMC anesthesiology·2026

Related Experiment Video

Updated: Jun 18, 2025

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
08:43

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Published on: August 26, 2021

2.4K

Pharmacologic, Surgical, and Device-Based Cardiac Neuromodulation.

Yuki Kuwabara1, Benjamin Wong1, Aman Mahajan1

  • 1Department of Anesthesiology and Perioperative Medicine of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA.

Cardiac Electrophysiology Clinics
|July 31, 2024
PubMed
Summary

Neuromodulation therapies offer new treatments for cardiac autonomic nervous system imbalances, improving cardiac disease management and patient symptoms. This review explores clinical neuromodulation techniques for heart conditions.

Keywords:
Baroreceptor stimulationCardiac autonomic nervous systemCardiac diseaseNeuromodulationSpinal cord stimulationStellate ganglion blockSympathetic denervationVagus nerve stimulation

More Related Videos

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System
06:40

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System

Published on: May 22, 2018

10.7K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.2K

Related Experiment Videos

Last Updated: Jun 18, 2025

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
08:43

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Published on: August 26, 2021

2.4K
Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System
06:40

Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System

Published on: May 22, 2018

10.7K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.2K

Area of Science:

  • Cardiology
  • Neuroscience
  • Medical Technology

Background:

  • The cardiac autonomic nervous system is crucial for heart function.
  • Disruptions in this system exacerbate cardiac diseases.
  • Autonomic imbalances negatively impact cardiac patients' conditions and symptoms.

Purpose of the Study:

  • To review current neuromodulation techniques for cardiac diseases.
  • To highlight emerging therapeutic options for autonomic nervous system imbalances.
  • To discuss the clinical application of neuromodulation in cardiology.

Main Methods:

  • Literature review of clinical studies.
  • Analysis of various neuromodulation techniques.
  • Synthesis of data on efficacy and application in cardiac care.

Main Results:

  • Neuromodulation therapies are increasingly used for cardiac conditions.
  • Several techniques aim to correct autonomic nervous system dysfunction.
  • These therapies show potential in managing cardiac disease symptoms.

Conclusions:

  • Neuromodulation represents a promising therapeutic avenue for cardiac patients.
  • Targeting autonomic imbalances can improve cardiac health outcomes.
  • Further research into clinical neuromodulation is warranted for cardiovascular diseases.